Loading data
CLNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.38 bn USD | 20.1 bn USD | 19.46 bn USD | 17.97 bn USD | 17.42 bn USD |
| Cost of revenue | 8.13 bn USD | 7.94 bn USD | 8.13 bn USD | 7.72 bn USD | 7.05 bn USD |
| Gross profit | 12.25 bn USD | 12.16 bn USD | 11.33 bn USD | 10.25 bn USD | 10.38 bn USD |
| Research and development expense | 366 m USD | 355 m USD | 343 m USD | 320 m USD | 307 m USD |
| Selling, general and administrative expense | 7.9 bn USD | 7.73 bn USD | 7.15 bn USD | 6.57 bn USD | 6.41 bn USD |
| Operating profit | 3.31 bn USD | 4.27 bn USD | 3.98 bn USD | 2.89 bn USD | 3.33 bn USD |
| Profit before tax | 3.06 bn USD | 3.96 bn USD | 3.39 bn USD | 2.66 bn USD | 3.09 bn USD |
| Income tax expense | 798 m USD | 907 m USD | 937 m USD | 693 m USD | 749 m USD |
| Net income (reported basis) | 2.13 bn USD | 2.89 bn USD | 2.3 bn USD | 1.79 bn USD | 2.34 bn USD |
| Net income attributable to common shareholders | 2.13 bn USD | 2.89 bn USD | 2.3 bn USD | 1.79 bn USD | 2.17 bn USD |
| Basic earnings per share | 2.64 USD/share | 3.53 USD/share | 2.78 USD/share | 2.13 USD/share | 2.56 USD/share |
| Diluted earnings per share | 2.63 USD/share | 3.51 USD/share | 2.77 USD/share | 2.13 USD/share | 2.55 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.